Alpine Immune Science, Inc. (ALPN/USD) Stages a Dramatic Ascent Fueled by a Bullish Frenzy
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 minutes to learn more
Alpine Immune Sciences (ALPN) has been on a tear since late 2023, defying gravity with a relentless upward climb. After shattering the $8.60 ceiling, ALPN comfortably established itself above $20 by year’s end. In the new year, the bullish fervor was renewed. The unrelenting buying pressure doubled the price, propelling it to $40 by late March. ALPN held steady at this level until a recent surge saw it aggressively challenge the $50 mark.
Alpine Immune Science, Inc. Market Data
- ALPN/USD Price Now: $47.23
- ALPN/USD Market Cap: $4.22 billion
- ALPN/USD Circulating Supply: 75 million
- ALPN/USD Total Supply: 50 billion
- ALPN/USD CoinMarketCap Ranking: #283
Key Levels
- Resistance: $50, $55, and $60.
- Support: $40, $35, and $30.
Alpine Immune Science, Inc. Market Analysis: The Indicators’ Point of View
The recent buying spree has fueled a meteoric rise for ALPN. This extended bullish run since late 2023 might be triggering Fear of Missing Out (FOMO) among some investors, further accelerating the climb. However, cautionary signs are emerging. Bollinger Bands and the Relative Strength Index (RSI) are hinting at an overbought market, suggesting a potential price correction. This correction could be significant given the recent rapid ascent. Additionally, profit-taking by investors wary of an impending correction could further dampen the momentum.
ALPN/USD 4-Hour Chart Outlook
ALPN’s sharp price surge has caused a noticeable divergence on the Bollinger Bands indicator. The RSI has also spiked above 70, reaching a peak of 85. This crypto signal suggests the market might be entering overbought territory, potentially leading to a period of profit-taking. While current profit-taking seems subdued compared to the recent bullish activity, the elevated RSI remains a cause for concern. Therefore, a price correction before reaching the $50 level is a distinct possibility.
